Trial · NCT02325713
Adverse events54
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 54
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Nausea | Gastrointestinal disorders | Treatment A: 40 mg/kg Test ODT-PZQ After Meal | 1 | 31 | |
| other | Nausea | Gastrointestinal disorders | Treatment B: 40 mg/kg Cysticide Tablet After Meal | 1 | 32 | |
| other | Nausea | Gastrointestinal disorders | Treatment C1: 20 mg/kg Test ODT-PZQ After Meal | 0 | 15 | |
| other | Nausea | Gastrointestinal disorders | Treatment C2: 60 mg/kg Test ODT-PZQ After Meal | 4 | 15 | |
| other | Nausea | Gastrointestinal disorders | Treatment D1: 40 mg/kg Test ODT-PZQ Without Meal | 0 | 14 | |
| other | Nausea | Gastrointestinal disorders | Treatment D2: 40 mg/kg Cysticide Crushed Tablets After Meal | 1 | 15 | |
| other | Vomiting | Gastrointestinal disorders | Treatment A: 40 mg/kg Test ODT-PZQ After Meal | 0 | 31 | |
| other | Vomiting | Gastrointestinal disorders | Treatment B: 40 mg/kg Cysticide Tablet After Meal | 1 | 32 | |
| other | Vomiting | Gastrointestinal disorders | Treatment C1: 20 mg/kg Test ODT-PZQ After Meal | 0 | 15 | |
| other | Vomiting | Gastrointestinal disorders | Treatment C2: 60 mg/kg Test ODT-PZQ After Meal | 0 | 15 | |
| other | Vomiting | Gastrointestinal disorders | Treatment D1: 40 mg/kg Test ODT-PZQ Without Meal | 0 | 14 | |
| other | Vomiting | Gastrointestinal disorders | Treatment D2: 40 mg/kg Cysticide Crushed Tablets After Meal | 0 | 15 | |
| other | Back Pain | Musculoskeletal and connective tissue disorders | Treatment A: 40 mg/kg Test ODT-PZQ After Meal | 0 | 31 | |
| other | Back Pain | Musculoskeletal and connective tissue disorders | Treatment B: 40 mg/kg Cysticide Tablet After Meal | 0 | 32 | |
| other | Back Pain | Musculoskeletal and connective tissue disorders | Treatment C1: 20 mg/kg Test ODT-PZQ After Meal | 1 | 15 | |
| other | Back Pain | Musculoskeletal and connective tissue disorders | Treatment C2: 60 mg/kg Test ODT-PZQ After Meal | 0 | 15 | |
| other | Back Pain | Musculoskeletal and connective tissue disorders | Treatment D1: 40 mg/kg Test ODT-PZQ Without Meal | 0 | 14 | |
| other | Back Pain | Musculoskeletal and connective tissue disorders | Treatment D2: 40 mg/kg Cysticide Crushed Tablets After Meal | 0 | 15 | |
| other | Muscle Spasms | Musculoskeletal and connective tissue disorders | Treatment A: 40 mg/kg Test ODT-PZQ After Meal | 0 | 31 | |
| other | Muscle Spasms | Musculoskeletal and connective tissue disorders | Treatment B: 40 mg/kg Cysticide Tablet After Meal | 0 | 32 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02325713/events